Literature DB >> 21544684

[Update Stroke Conference 2011: International Stroke Conference 2011, Los Angeles, USA].

M Ebinger, M Endres.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21544684     DOI： 10.1007/s00115-011-3299-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  26 in total

1.  Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study.

Authors:  Helen Lavretsky; Ling Zheng; Michael W Weiner; Dan Mungas; Bruce Reed; Joel H Kramer; William Jagust; Helena Chui; Wendy J Mack
Journal:  Am J Psychiatry       Date:  2010-02-16       Impact factor: 18.112

2.  Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.

Authors:  Gregg C Fonarow; Eric E Smith; Jeffrey L Saver; Mathew J Reeves; Deepak L Bhatt; Maria V Grau-Sepulveda; DaiWai M Olson; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm
Journal:  Circulation       Date:  2011-02-10       Impact factor: 29.690

3.  Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials.

Authors:  R Loch Macdonald; Randall T Higashida; Emanuela Keller; Stephan A Mayer; Andy Molyneux; Andreas Raabe; Peter Vajkoczy; Isabel Wanke; Aline Frey; Angelina Marr; Sébastien Roux; Neal F Kassell
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

4.  Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.

Authors:  Peter M Rothwell; Sally C Howard; Eamon Dolan; Eoin O'Brien; Joanna E Dobson; Bjorn Dahlöf; Neil R Poulter; Peter S Sever
Journal:  Lancet Neurol       Date:  2010-03-11       Impact factor: 44.182

5.  Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.

Authors:  François Chollet; Jean Tardy; Jean-François Albucher; Claire Thalamas; Emilie Berard; Catherine Lamy; Yannick Bejot; Sandrine Deltour; Assia Jaillard; Philippe Niclot; Benoit Guillon; Thierry Moulin; Philippe Marque; Jérémie Pariente; Catherine Arnaud; Isabelle Loubinoux
Journal:  Lancet Neurol       Date:  2011-01-07       Impact factor: 44.182

6.  Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke.

Authors:  Bruce C V Campbell; Søren Christensen; Kenneth S Butcher; Ian Gordon; Mark W Parsons; Patricia M Desmond; P Alan Barber; Christopher R Levi; Christopher F Bladin; Deidre A De Silva; Geoffrey A Donnan; Stephen M Davis
Journal:  Stroke       Date:  2009-12-03       Impact factor: 7.914

7.  NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.

Authors:  Hans-Christoph Diener; Kennedy R Lees; Patrick Lyden; Jim Grotta; Antoni Davalos; Stephen M Davis; Ashfaq Shuaib; Tim Ashwood; Warren Wasiewski; Vivian Alderfer; Hans-Goran Hårdemark; Larry Rodichok
Journal:  Stroke       Date:  2008-03-27       Impact factor: 7.914

8.  The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors.

Authors:  Joachim Schrader; Stephan Lüders; Anke Kulschewski; Jürgen Berger; Walter Zidek; Johannes Treib; Karl Einhäupl; Hans Christoph Diener; Peter Dominiak
Journal:  Stroke       Date:  2003-06-19       Impact factor: 7.914

9.  Migraine headache in middle age and late-life brain infarcts.

Authors:  Ann I Scher; Larus S Gudmundsson; Sigurdur Sigurdsson; Anna Ghambaryan; Thor Aspelund; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer
Journal:  JAMA       Date:  2009-06-24       Impact factor: 56.272

10.  The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

Authors:  Else Charlotte Sandset; Philip M W Bath; Gudrun Boysen; Dalius Jatuzis; Janika Kõrv; Stephan Lüders; Gordon D Murray; Przemyslaw S Richter; Risto O Roine; Andreas Terént; Vincent Thijs; Eivind Berge
Journal:  Lancet       Date:  2011-02-26       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.